SCHEMBL6703875

SCHEMBL6703875

CN(C1CC1)S(=O)(=O)c1ccc(NCC(C)(C)N)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
GAA P10253 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
TP53 P04637 1/20 0.40
HTR2A P28223 4/20 0.40
HTR2C P28335 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
ALOX12 P18054 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509089 0.85 HPGD (0.49) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6698781 0.79 HPGD (0.43) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6701251 0.78 KDM4E (0.44) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6702326 0.78 HPGD (0.43) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6703201 0.78 HPGD (0.43) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL2567939 0.76 GAA (0.58) SMN1; SMN2LMNAALDH1A1KDM4EMEN1
SCHEMBL6702241 0.76 MAPT (0.46) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6698773 0.75 ALDH1A1 (0.44) HPGDSMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6702882 0.72 DPP4 (0.69)
SCHEMBL6704223 0.72 KDM4E (0.64) LMNAALDH1A1KDM4EGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-09-16 US disclosed
EP-1354882-A1 DIPEPTIDYL PEPTIDASE IV INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor DPP4, DPP3, DPP9 HPGD 2000/4885SMN1; SMN2 3810/4885LMNA 4630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.